Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study

BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) is the primary target of lipid-lowering therapy on the management of hypercholesterolemia in the United States and European guidelines, while apolipoprotein B (apoB) is the secondary target. The objective was to determine if elevated levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Tianci, Lu, Weilin, Ke, Jinshan, Zhang, Hao, Zhao, Xiaofang, Song, Bei, Liu, Ting, Ke, Qinmei, Liu, Chengyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097510/
https://www.ncbi.nlm.nih.gov/pubmed/35573992
http://dx.doi.org/10.3389/fendo.2022.865863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097510/
https://www.ncbi.nlm.nih.gov/pubmed/35573992
http://dx.doi.org/10.3389/fendo.2022.865863

Ejemplares similares